262 related articles for article (PubMed ID: 10546132)
21. [Implantable automatic defibrillator after MADIT and EMIAT].
Farré J
Rev Esp Cardiol; 1996 Oct; 49(10):709-13. PubMed ID: 9036472
[No Abstract] [Full Text] [Related]
22. [Heart failure: causes and therapy of unstableness].
Opasich C; Sinagra G
G Ital Cardiol; 1995 Nov; 25(11):1433-7. PubMed ID: 8682240
[No Abstract] [Full Text] [Related]
23. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Mitchell LB
J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
[No Abstract] [Full Text] [Related]
24. Implantable cardiac defibrillators.
Spivack C
N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
[No Abstract] [Full Text] [Related]
25. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials?
Kam RM; Teo WS; Koh TH; Lim YL
Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412
[TBL] [Abstract][Full Text] [Related]
26. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
Cucherat M
Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
[TBL] [Abstract][Full Text] [Related]
27. [Cardiovascular disease in women. Why now?].
Alfonso F; Bermejo J; Segovia J
Rev Esp Cardiol; 2006 Mar; 59(3):259-63. PubMed ID: 16712750
[No Abstract] [Full Text] [Related]
28. Myocardial infarction--secondary prevention.
Hjalmarson A
Acta Med Scand Suppl; 1986; 712():35-9. PubMed ID: 2880462
[No Abstract] [Full Text] [Related]
29. [Cardiopulmonary resuscitation. Simpler is more effective: the current guidelines].
Reinecke H; Breithardt G
Med Klin (Munich); 2003 Nov; 98(11):629-39. PubMed ID: 14631538
[No Abstract] [Full Text] [Related]
30. [Therapy of hypertrophic cardiomyopathy].
Cecchi F; Olivotto I
G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
[No Abstract] [Full Text] [Related]
31. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
Eckardt L; Breithardt G
Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
[No Abstract] [Full Text] [Related]
32. Randomized clinical trials: how long should they last?
Wellens HJ
Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
[No Abstract] [Full Text] [Related]
33. Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
Kennedy HL
Am J Cardiol; 1997 Nov; 80(9):1208-11. PubMed ID: 9359552
[No Abstract] [Full Text] [Related]
34. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
Campbell TJ
Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
[No Abstract] [Full Text] [Related]
35. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
36. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
Tung R; Zimetbaum P; Josephson ME
J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
[TBL] [Abstract][Full Text] [Related]
37. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
38. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients.
Bestetti R; Cardinalli-Neto A
Europace; 2009 Apr; 11(4):537. PubMed ID: 19279026
[No Abstract] [Full Text] [Related]
40. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
Disertori M; Dallafior D; Marini M
Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
